November 13, 2025
admin
Shilpa Medicare – Strong YoY Profit Rebound
Shilpa Medicare has delivered an impressive turnaround in September 2025 results. Sales grew 8% YoY to Rs. 370 crore, supported by better operating efficiency. EBIDT jumped 26% to Rs. 108 crore, reflecting improved margins. The biggest highlight is the 146% surge in net profit to Rs. 44.1 crore, compared to Rs. 18 crore last year. EPS has more than doubled to Rs. 2.25 (vs Rs. 0.92 YoY), signalling a sharp recovery in profitability. Overall, the pharma company continues its steady momentum with strong bottom-line growth.
👉 GMP | Reviews | Subscription | Allotment Affiliate: Sahifund.com
